Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -39.82 | 19.21 |
| PEG Ratio (TTM) | 0.07 | 16.39 |
| P/S Ratio (TTM) | 3.04 | 6.95 |
| P/B Ratio (TTM) | 3.49 | 5.99 |
| P/FCF Ratio (TTM) | 36.78 | 17.74 |
| Price to 5YR AVG Earnings Ratio | -41.82 | 98.50 |
| Price to 5YR AVG FCF Ratio | 23.97 | 33.03 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -3.98% | 0.45% |
| ROE (TTM) | -7.97% | 8.86% |
| Net Profit Margin (TTM) | -7.57% | 2.94% |
| ROIC 5YR AVG | -2.72% | 11.51% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 186.28% | -232.85% | -130.38% |
| Revenue | 1.54% | 44.27% | 26.70% |
| Net Income | 181.71% | -134.11% | -71.87% |
| Cash Flow | 29.82% | 59.29% | 30.84% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 7.32 | 2.45 |
| Quick Ratio (TTM) | 7.32 | 2.27 |
| D/E Ratio (TTM) | 0.98 | 0.73 |
| Interest Coverage (TTM) | -0.22 | 6.45 |
| Piotroski F-Score | 4 | 5 |
| Altman Z-Score | 1.43 | 7.33 |
| LTL to 5YR AVG FCF | 6.59 | 1.12 |
| Shares Outstanding Growth 5YR AVG | 2.92% | 4.81% |